Lv15
40 积分 2024-02-08 加入
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis
19小时前
已完结
Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen‐induced seasonal allergic rhinitis
1天前
已完结
Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR
1天前
已完结
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
1天前
已完结
Omalizumab is Effective and Safe in the Treatment of Japanese Cedar Pollen-induced Seasonal Allergic Rhinitis
1天前
已完结
Omalizumab (Xolair) in children with seasonal allergic rhinitis: Leukotriene release as a potential in vitro parameter to monitor therapeutic effects
1天前
已完结
Safety of anti‐IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously
3天前
已完结
Sustained Efficacy Assessed By Number Needed to Treat for Timothy Grass Immunotherapy Tablets in the Treatment of Allergic Rhinitis with/without Conjunctivitis up to 2 Years after 3 Years of Treatment
3天前
已完结
Combination of omalizumab with allergen immunotherapy versus immunotherapy alone for allergic diseases: A meta‐analysis of randomized controlled trials
3天前
已完结
Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials
3天前
已完结
皖公网安备34019202002308
